Endothelin-I receptor antagonist for the treatment of pulmonary arterial hypertension in systemic sclerosis. Current rheumatology reports. [Curr Rheumatol Rep] Journal article

Title	Endothelin-I receptor antagonist for the treatment of pulmonary arterial hypertension in systemic sclerosis.
Author(s)	Varga J
Source	Curr Rheumatol Rep 2003 Apr; 5(2):145-6.
MeSH	Antihypertensive Agents Endothelin-1 Humans Hypertension, Pulmonary Lung Randomized Controlled Trials Receptors, Endothelin Scleroderma, Systemic Sulfonamides Treatment Outcome
Language	eng
Pub Type(s)	Journal Article
PubMed ID	12628045

Advertise on this site.